Algemeen
Code
AZGS2024003
Naam
Triumph
Omschrijving
TRIUMPH: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Retatrutide on the Incidence of Major Adverse Cardiovascular Events and the Decline in Kidney Function in Participants with Body Mass Index =27 kg/m2 and Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease
Start inclusieperiode
6-6-2024
Einde inclusieperiode
1-6-2025
Contact
Coördinator
Feebe D'Hondt
Telefoon
056633188
Email
feebe.dhondt@azgroeninge.be